Three held for beating murder accused to death after tying him to tree

Mysuru, Apr 7 Following a tiger at Bronx Zoo in the US, testing positive for COVID-19, Mysuru Zoo authorities here have taken measures to contain the spread of the dreaded disease as per the directions of the Central Zoo Authority (CZA).

The Zoo is on alert and the animal keepers are not allowed to enter the enclosures without safety gear. It is mandatory for the personnel to undergo thermal screening before entering the Zoo. The personnel are provided with safety gears such as masks, gloves and Sanitisers. The CZA has directed to spray disinfectants near the enclosures of the animals and has also directed to monitor the animals’ behavior.

Zoo Authority of Karnataka Member Secretary B P Ravi said, "COVID-19 was detected in a domestic cat two weeks back in Hong Kong. Due to the outbreak of bird flu in Mysuru, we have taken all precautionary measures to combat COVID-19."

Bengaluru, Apr 21: An FIR has been filed against a Kannada TV anchor allegedly for organising a guest packed wedding at a resort near Bengaluru last week amid lockdown to contain the spread of coronavirus.

Police got the tip-off about the event held on April 18 by locals residing near the resort. Around 20 people were present there to attend the wedding.

The FIR has been filed under National Disaster Management Act (NDMA) and Section 188 and 269 of the Indian Penal Code.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.